We market well.

Your agency should fully understand your product and the science. Then, there’s the marketplace. Grasping all three dynamics is a specialized field. Ours.

Our philosophy implies there are no excuses for boring and dull. The medical industry deserves better.

Spread the word. Big or small. Any time, any place. Right now, today. Don’t wait, hesitate or ruminate. We can help all medical companies. We’d like to make your brand our next success story.

A CASE STUDY CLICK HERE
to review a copy of the book
NOW IN PROGRESS
World’s 2nd most popular
search engine? YouTube.

People are naturally interested in other humans and information.
Attract, educate and engage with videos that tell your story—just keep it brief.
SEE MORE
recent work right here
The Medical News
NEW YORK (Reuters) - CVS Corp’s proposed purchase of Aetna Inc will affect decision-making by a majority of large and mid-size U.S. corporations on employee health benefits, a survey by benefits consultant Aon Plc found.... ZURICH (Reuters) - Roche's patent dispute with London-listed Shire over the Swiss drugmaker's new haemophilia drug Hemlibra has escalated, with Shire filing a new motion in a U.S. court that Roche says aims to stop some patients from getting its medicine.... CHICAGO (Reuters) - Hamburger chain Wendy's Co laid out plans on Friday to trim the use of antibiotics that are important to human medicine from its beef supply, the latest step by a food company to fight concerns about resistance to the drugs in people.... (Reuters) - A U.S. judge on Friday blocked President Donald Trump's administration from moving forward with new rules that undermined an Obamacare requirement for employers to provide health insurance that covers women's birth control.... FREETOWN (Reuters) - Two Ebola survivors in Sierra Leone filed a lawsuit in a regional court on Friday, accusing the government of mismanaging funds during an epidemic that killed more than 3,000 people in the West African nation.... FRANKFURT (Reuters) - Germany's Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the U.S. market, hoping for blockbuster sales despite regulatory concerns about side effects having frustrated its ambitions almost seven years ago.... LONDON (Reuters) - An ingredient in cannabis called cannabidiol or CBD has shown promise in a clinical trial as a potential new treatment for psychosis, scientists said on Friday.... COPENHAGEN (Reuters) - Following a string of food safety scandals, Chinese tourists visiting Copenhagen have this year stocked up on Danish-made organic infant milk formula, prompting some supermarkets to limit the number of cans each customer can buy.... (Reuters Health) - Women with sleep disorders other than sleep apnea may be more than three times as likely to experience infertility as their counterparts who don’t have trouble sleeping, a recent study suggests.... (Reuters Health) - People who have so-called transient neurological attacks, including brief mini-strokes, may develop cognitive problems that linger for months, a recent study suggests....